Madarimot, Delma R.
HRN: 23-46-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/23/2023
10/29/2023
IV
4.5gm
IV
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes